As of August 28, 2026, Avaí Bio, Inc. (AVAI) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Avaí Bio, Inc. has a market capitalization of $27.65M, 153.92M shares outstanding.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.31 below $1 exchange minimum
• Only 2 months cash — financial pressure
💰 Capital Raise
model 55%
• Critical: only 1.7 months cash remaining
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (65/100)
Market Data
Market Cap$27.65M
Shares Outstanding153.92M
Float68.71M
Cash$83.6K
Debt$30.0K
Short InterestN/A
Institutional Holdings
Institutional data not yet available.
Short Interest
Short Interest2.0K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2026-03-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual AVAI Dilution Snapshot
Avaí Bio, Inc. (AVAI) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for AVAI: xbrl on 2026-03-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track AVAI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AVAI — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required